Integrative Cancer Therapy – The Latest Tools from A to Z

Integrative Cancer Therapy – The Latest Tools from A to Z

By Ahmad Nasri, HD

In this twenty first century, the word “cancer” still strikes terror in the hearts of most people – particularly those who have seen a loved one suffer from it. Cancer, in its various forms, is the second leading cause of death after heart disease.

The following are several researched alternative cancer treatment modalities employed by different health professionals all over the globe. They have been shown to enhance conventional chemotherapy and radiation treatment, decrease side effects of these base therapies, and dramatically increase survival times in virtually all stages of most cancers. They can be viewed under the following four general lines:

Decreasing the Tumour Load

• Poly MVA – This compound is a non-toxic polynucleotide reductase. The MVA stands for minerals, vitamins, and amino acids. Lipoic acid is a natural powerful antioxidant that is both water and fat soluble, which permits the Poly-MVA to pass across the cell membranes and the blood brain barrier, which is impossible for most drugs, including chemotherapy. When it enters cancer cells, protein radicals are formed which denature the tumour cell’s proteins. Since “normal cells” are capable of converting the radicals into energy and water, no harm can occur. LAPd stands for Lipoic acid / Palladium complex.

The original human trials were done in Canada by the late oncologist, Dr. Rudy Falk, usually in conjunction with standard chemotherapy for more than five years. He reported benefits including pain reduction or control, improved appetite and weight gain, and increased energy. Some patients are still using low doses of Poly-MVA and have no signs of cancer after ten years of use.1 A recent study presented at the American Academy for Anti-Aging Medicine (A4M) by an American oncologist shows a 77% response rate of Stage IV cancer patients treated with intravenous and oral Poly MVA.

The most dramatic responses were noted with brain tumours. Other tumours that respond well are breast, ovarian, prostate, colon, and lung cancer, among others.

• Hyaluronic Acid (HA) – This is a naturally occurring substance and as part of the extra cellular matrix is present throughout all tissue and surrounding cells. Because of the altered status of the tumour, its anaerobic metabolism, and its abnormal vasculature, only a small portion of the tumour is affected by cytotoxic drugs. However, by mixing them physically with HA, they loosely combine and will target the sites where HA is deficient, and across the blood brain barrier.

Clinical studies showed that the use of HA as a carrier/targeting vehicle can enhance the effect of some, if not all, drugs such as NSAIDs, immunosuppressive agents, cytotoxic anticancer drug therapy, and drugs for relief of atheromatous blood vessel disease.2 Investigations have moreover shown that tumours possess several HA receptors (CD44, RHAMM, etc.). This fact explains that HA will help cytotoxic drugs act specifically with the tumour cells, thus reducing their side effects on other normal cells.3

•Angiogenesis inhibition – Another therapeutic target is the endothelial cells that form new blood vessels around tumours. The process by which new blood vessels are formed is called angiogenesis, and cancer cells initiate blood vessel proliferation in order to fuel rapid growth. Agents that interfere with formation of new blood vessels are an important part of a comprehensive treatment strategy. They effectively interfere with cancer's various growth pathways and inhibit production of blood vessels.2

Non steroidal anti-inflammatories (NSAID’S) and COX II inhibitors combined with Hyaluronic acid and vitamin C present a very efficient action on the cancerous endothelial cells. This is mediated through the ICAM 1 receptors.3 They also markedly help reduce cancer related pain and assist patients in avoiding morphine. Other angiogenesis agents include curcumin, green tea, etc.

•Intravenous Vitamin C – A growing number of studies in vitro, as well as in vivo, suggest the use of high dose intravenous vitamin C as an adjunctive therapy for cancer patients. Because of a relative catalase deficiency in tumour cells, they are more susceptible to the effects of high-dose ascorbate induced peroxidation products. Concentrations of ascorbate high enough to kill tumour cells can be achieved in humans.4

The addition of magnesium and Vitamin B6 does inhibit oxalate stone formation in stone formers. Patients should also be screened for red blood cell G6PD deficiency to prevent hemolysis.5 The addition of other trace elements and minerals will also help provide nutrition to the normal cells deprived by the presence of cancer. This will help increase the patient’s energy level.  

Immunotherapies

In order for cancer to occur, the immune system must have failed. So what went wrong? Extensive research has revealed that the main problem lies at the level of the dendritic cells. These are the cells that hand off the tumour cell information to the natural killer cells so the immune system can destroy the tumour. In cancer patients they are in and around the tumour, but they are immature. Moreover because they are immature, they are much less likely to migrate to lymph nodes to make the hand off.

• Dendritic Cell Vaccine – Through the tumour tissue specimen or urine collection, a comprehensive cancer vaccine could be prepared which is comprised of: Tumor-specific antigen injections; Cytokine injections to stimulate dendritic cells maturation; Heat shock protein/tumor specific antigen injections that act as “antigen chaperones” to the dendritic cells.6

Clinical responses were reported in greater than 40% in breast cancer patients of all stages, 63% in melanoma, and a 67% response in non-Hodgkin’s lymphoma patients. Other cancers including colorectal, lung, mesothelioma, ovarian, pancreatic, prostate, and thyroid have also shown significant clinical responses to the immunotherapy.7

• Oxygenation Therapies – The most fundamental feature of a cancer cell is that it is relatively anaerobic. It needs sixty percent less oxygen than a normal healthy cell. It does very poorly in the presence of excess oxygen. All of this points toward oxidative therapies as a decent treatment for cancer and a decent preventive measure as well. These include ozone, hydrogen peroxide, and hyperbaric oxygen.

Ozone, referred to as O3, is produced in a generator using pure oxygen. In Major Auto Hemotherapy (MAH), blood is drawn, mixed with ozone for a few seconds, and reinjected. The improvement in the immune system is demonstrated by increased natural killer cell activity. In vitro studies have shown that cancer cultures treated with ozone along with 5-FU did not develop resistance to chemotherapy, as did the untreated colonies. This adjunctive therapy with chemotherapy and radiation is further enhanced if MAH is used at the same time with Ultraviolet Blood Irradiation Therapy (UBIT).8

• Ney Tumorin – This is a biomodular homeopathic German medication for the treatment of cancer. It activates the immune system on one hand and also influences directly the differentiation of the tumour cell. It has a zytostatic effect due to its ingredients such as liver and placenta.9

• Ney Thymun – This is a first line homeopathic choice in thymus therapy. Only on contact with thymus factors do precursor cells derived from the bone marrow develop into mature, immunologically competent cytotoxic T lymphocytes. Clinical studies have shown that Ney thymun increases the functional power of T lymphocytes, stimulates natural killer cells, produces an increase in autogenic interferons, and inhibits the growth of melanoma cells. 10

• Natural Killer cell stimulants – These include AHCC, MGN III, IP6, NK Immune, etc.

• Iscador – Mistletoe contains a cytotoxic lectin (viscumin) which is both cytotoxic and immunostimulatory. It induces tumour necrosis, increases natural killer cell activity, increases production of interleukins 1 and 6. It also activates macrophages, induces programmed cell death (apoptosis), and protects DNA in normal cells during chemotherapy.

A German study done by Dr. Ronald Grossarth-Maticek of the Institute for Preventive Medicine in Heidelberg shows that, when used as adjunctive treatment in patients with a variety of cancers, it can increase survival time by as much as 40%. Research indicates that mistletoe extract is most effective when used in conjunction with conventional medical care for the treatment of solid tumours such as breast cancer.

• Wob-Mugos and Wobenzyme – This is a formula containing several kinds of hydrolytic, proteolytic enzymes from plant and animal sources that attack cancer in several ways. First, it attacks the coating on tumour cells, which disguise them from recognition by the immune system that the antigens are exposed to. Second, it stimulates various components of the immune system such as Natural Killer cells, T-cells and Tumour Necrosis factor. Third, it removes the "sticky" coating on cancer cells that allow them to adhere to other parts of the body, in effect lessening the chances of metastasis.

Detoxification, Lifestyle and Diet Changes

Removal of toxins (heavy metals, xenoestrogens, pesticides) from the body is considered as a very important part of the treatment. A variety of approaches are used, including colon cleansing, fasting, chelation, water therapy, heat therapy, and nutritional, herbal, and homeopathic methods. This causes the liver to release stored up toxins into the digestive system to be eliminated. Increasing water intake another excellent way to get rid of toxins in the body.
Likewise, it is very important to implement good nutrition, exercise, and maintain emotional balance. Avoid preservatives, chemicals, coffee, cigarettes, alcohol, red meats, and sugar. The diet should be based on organic whole grains, beans, juicing raw vegetables, and some low sugar fruits.  

Body Mind and Energy Therapies

These forms of therapies can be applied to support behavioural patterns during recovery. Many patients with chronic illness or cancer mal-adapt to their situation and the brain becomes satisfied with that level of function. Although it may not be the cause of the disorder, it’s a common cause for a patient’s poor response to biological treatment because it can block the immune response. Meditation and Reiki are healing techniques that help balance physical, mental, and emotional energy flows. Reflexology stimulates healing using pressure points on feet and hands.
Finally I hope that this will help cancer patients looking for integrative cancer therapies learn about different available treatment options. The good news is that all these therapies are available here in Ontario. This implies that patients need not seek therapies in other clinics abroad (Mexico, Germany, United States, etc.). Therefore, they can save a lot on the economical and emotional stress, and more importantly, assure that they are receiving health follow-ups locally.
(Note: It is impossible to get a grip on the battle with cancer in just three or four week treatments. A long term commitment is required.)

Ahmad Nasri received his Medical Doctorate and General Surgeon training in the Dominican Republic. He is also a certified Homeopathic practitioner in Ontario. He is an experienced professional with a vast knowledge and renowned speaker in Integrative cancer therapy, Chelation therapy, and Anti aging. He is Director of the Nasri Chelation and Integrative Medicine in Barrie (705) 735-2354 and Toronto (905) 266-0959,  www.nasrichelation.com.

References
1- Poly-MVA, Cancer Breakthrough, Al Sanchez. AMARC: Chula Vista, California 91910.
2- 1st International Workshop on Hyaluronan in Drug Delivery. Windsor, UK 1992.
3- 4th International Workshop on Hyaluronan in Drug Delivery. Gressy, France, 1996.
4-Clinical & Experimental experiences with Intravenous Vitamin C. Bio-Communications research institute, Wichita, Kansas, 67219.
5-RECNAC, Protocol for the use of High Dose Intravenous Ascorbate as a Cytotoxic Chemotherapeutic agent. Wichita, Kansas, 67219.
6-Tomorrow’s cancer vaccine today. Neil H. Riordan, 1999.
7- Autologous Immunotherapy of Cancer. J. L. McCoy, Ph.D. Stockbridge, GA 30281.
8- The Principles and Applications of Ozone Therapy, by F. Shallenberger, MD. 1999.
9- Treatment Schedule Proposal with NeyTumorin. Vitorgan, Ostfildren, Germany.
10- Ney Thymun, a first choice in Thymus-therapy. Vitorgan, Ostfildren, Germany.